Cathay Biotech Inc. (SHA:688065)
China flag China · Delayed Price · Currency is CNY
41.42
-1.00 (-2.36%)
Sep 4, 2026, 3:00 PM CST

Cathay Biotech Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,5243,2952,9582,1142,4412,363
Revenue Growth
10.68%11.40%39.91%-13.39%3.28%57.86%
Gross Profit
1,162991.2836.44579.23829.2837.21
Operating Income
717.5526.78396.1165.55406.61499.25
Net Income
624.78560.72488.96366.52553.27594.72
Earnings Per Share
0.880.820.840.630.951.02
EPS Growth
-2.02%-2.38%33.33%-33.68%-6.86%21.01%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
Biological Long-Chain Dibasic Acid
2,935
Bio-Based Polyamide
127.41
Others
57.84
Total
3,120

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9,2989,2525,3475,3916,2959,629
Total Debt
707.75031,8971,7761,127743.51
Net Cash (Debt)
8,5918,7493,4503,6155,1688,886
Net Cash Growth
-7.31%153.60%-4.56%-30.05%-41.84%26.22%
Net Cash Per Share
12.0312.795.936.218.8715.24

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
815.41404.12820.93569.45803.67578.69
Capital Expenditures
-937.27-743.46-843.31-1,570-4,198-1,459
Free Cash Flow
-121.86-339.34-22.38-1,000-3,395-880.49
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
32.98%30.08%28.28%27.40%33.97%35.42%
Operating Margin
20.36%15.99%13.39%7.83%16.66%21.12%
Pretax Margin
20.29%19.12%18.53%21.23%28.51%30.65%
Profit Margin
17.73%17.02%16.53%17.34%22.66%25.16%
FCF Margin
-3.46%-10.30%-0.76%-47.32%-139.06%-37.25%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.4500.4500.4000.1900.1800.321
Dividend Per Share Growth
12.50%12.50%110.53%5.56%-43.99%-43.75%
Dividend Yield
1.07%0.91%1.05%0.35%0.30%0.25%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
47.3264.0146.1387.3464.61129.11
Forward PE
34.1648.4729.6146.7438.3189.61
PS Ratio
8.4710.897.6315.1414.6532.49